MetaVia Inc. (NASDAQ:MTVA) Short Interest Up 489.9% in May

MetaVia Inc. (NASDAQ:MTVA) saw a significant increase in short interest in the month of May. As of May 29th, there was short interest totaling 408,434 shares, an increase of 489.9% from the May 14th total of 69,235 shares. Approximately 8.0% of the shares of the company are sold short. Based on an average daily volume of 21,957,148 shares, the short-interest ratio is presently 0.0 days.

Analyst Upgrades and Downgrades

MTVA has been the topic of a number of research analyst reports. Wall Street Zen upgraded shares of MetaVia from a “sell” rating to a “hold” rating in a research report on Saturday, March 28th. Weiss Ratings restated a “sell (e+)” rating on shares of MetaVia in a research report on Friday, April 24th. Finally, HC Wainwright restated a “buy” rating and set a $20.00 price objective on shares of MetaVia in a research report on Monday, May 18th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, MetaVia presently has an average rating of “Hold” and an average target price of $20.00.

MetaVia Stock Up 3.7%

MTVA traded up $0.07 during trading on Wednesday, hitting $1.96. The company’s stock had a trading volume of 235,673 shares, compared to its average volume of 2,230,112. MetaVia has a one year low of $0.97 and a one year high of $19.03. The firm has a market cap of $10.11 million, a PE ratio of -0.38 and a beta of 0.92. The business’s 50 day simple moving average is $1.81 and its 200-day simple moving average is $3.69.

MetaVia (NASDAQ:MTVA) last released its quarterly earnings results on Thursday, May 14th. The company reported ($0.79) earnings per share for the quarter, missing the consensus estimate of ($0.76) by ($0.03). Equities research analysts expect that MetaVia will post -2.78 EPS for the current fiscal year.

Institutional Trading of MetaVia

A hedge fund recently bought a new stake in MetaVia stock. Virtu Financial LLC acquired a new stake in shares of MetaVia Inc. (NASDAQ:MTVA) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 32,755 shares of the company’s stock, valued at approximately $31,000. Virtu Financial LLC owned about 0.14% of MetaVia as of its most recent SEC filing. 1.37% of the stock is currently owned by institutional investors.

About MetaVia

MetaVia Inc is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. MetaVia Inc, formerly known as NeuroBo Pharmaceuticals Inc, is based in CAMBRIDGE, Mass.